Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 771-776

  Lovell, Mark A ^a,b   Gabbita, S Prasad ^a   Markesbery, William R ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; CSF; DNA oxidation; Gas chromatography mass spectrometry with selective ion monitoring; Oxidative stress; Ventricular

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DNA;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN LATERAL VENTRICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

EID: 0032933750     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720771.x     Document Type: Article

References (44)

1. Adelman R., Saul R. L., and Ames B. N. (1988) Oxidative damage to DNA: relation to species metabolic rate and life span. Proc. Natl. Acad. Sci. USA 85, 2706-2708.
2. Ames B. N. (1989) Endogenous oxidative DNA damage, aging, and cancer. Free Radic. Res. Commun. 7, 121-128.
3. Chung M.-H., Kasai H., Jones D. S., Inoue H., Ishikawa H., Ohtsuka E., and Nishimura S. (1991a) An endonuclease activity of Escherichia coli that specifically removes 8-hydroxyguanine residues from DNA. Mutat. Res. 254, 1-12.
4. Chung M.-H., Kim H.-S., Ohtsuka E., Kasai H., Yamamoto F., and Nishimura S. (1991b) An endonuclease activity in human polymorphonuclear neutrophils that removes 8-hydroxyguanine residues from DNA+. Biochem. Biophys. Res. Commun. 178, 1472-1478.
5. Dizdaroglu M. (1993) Quantitative determination of oxidative base damage in DNA by stable isotope-dilution spectrometry. FEBS Lett. 315, 1-6.
6. Ehmann W. D., Markesbery W. R., Alauddin M., and Hossain T. I. M. (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 197-206.
7. Fraga C. G., Shigenaga M. K., Park J. W., Degan P., and Ames B. N. (1990) Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 87, 4533-4537.
8. Gabbita S. P., Lovell M. A., and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 71, 2034-2040.
9. Good P. F., Perl D. P., Bierer L. M., and Schmeidler J. (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286-292.
10. Good P. F., Werner P., Hsu A., Olanow C. W., and Perl D. P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
11. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
12. Hyman B. T., Tanzi R. E., Marzloff K., Barbour R., and Schenk D. (1992) Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 51, 76-83.
13. Kamiya H., Murata-Kamiya N., Fujimuro M., Kido K., Inoue H., Hishimura S., Masutani C., Hanaoka F., and Ohtsuka E. (1995) Comparison of incorporation and extension of nucleotides in vitro opposite 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene. Jpn. J. Cancer Res. 86, 270-276.
14. Kuchino Y., Mori F., Kasai H., Inoue H., Iwai S., Miura K., Ohtsuka E., and Nishimura S. (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327, 77-79.
15. Loft S. and Poulsen H. E. (1996) Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74, 297-312.
16. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
17. Lovell M. A., Ehmann W. D., Mattson M. P., and Markesbery W. R. (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18, 457-461.
18. Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
19. Markesbery W. R. and Lovell M. A. (1998) 4-Hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 33-36.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
21. Mecocci P., MacGarvey U., Kaufmann A. E., Koontz D., Shoffner J. M., Wallace D., and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34, 609-616.
22. Mecocci P., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
23. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., Van Belle G., and Berg L. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
24. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O., Graham D. G., and Montine T. J. (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150, 437-443.
25. 2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44, 410-413.
26. National Institute on Aging, and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S1-S2.
27. Prasad M. R., Lovell M. A., Yatin M., Dhillon H., and Markesbery W. R. (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23, 81-83.
28. Samudralwar D. L., Diprete C. C., Ni B. F., Ehmann W. D., and Markesbery W. R. (1995) Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130, 139-145.
29. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
30. Shibutani S., Takeshita M., and Grollman A. P. (1991) Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349, 431-434.
31. Shigenaga M. K., Gimeno C. J., and Ames B. N. (1989) Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA 86, 9697-9701.
32. Shigenaga M. K., Aboujaoude E. N., Chen Q., and Ames B. N. (1994) Assays of oxidative DNA damage biomarkers 2-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol. 234, 16-33.
33. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
34. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stem D., Sayre L. M., Monnier V. M., and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710-5714.
35. Smith M. A., Sayre L., Monnier V., and Perry G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
36. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., and Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
37. Smith M. A., Harris P. L. R., Sayre L. M., and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94, 9866-9868.
38. Smith M. A., Hirai K., Hsiao K., Pappolla M. A., Harris P. L. R., Sidelah S. L., Tabaton M., and Perry G. (1998) Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 2212-2215.
39. Svennerholm L. and Gottfries C.-G. (1994) Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62, 1039-1047.
40. Tchou J., Kasai H., Shibutani S., Chung M.-H., Laval J., Grollman A. P., and Nishimura S. (1991) 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. USA 88, 4690-4694.
41. TeKoppele J. M., Lucassen P. J., Sakkee A. N., Van Asten J. G., Ravid R., Swaab D. F., and Van Bezooijen C. F. (1996) 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease. Neurobiol. Aging 17, 819-826.
42. Thompson C. M., Markesbery W. R., Ehmann W. D., Mao Y.-X., and Vance D. E. (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1-8.
43. Wagner J. R., Hu C.-C., and Ames B. N. (1992) Endogenous oxidative damage of deoxycytidine in DNA. Proc. Natl. Acad. Sci. USA 89, 3380-3384.
44. Yan S. D., Chen X., Schmidt A.-M., Brett J., Godman G., Zou Y. S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S. H., and Stern D. (1994) Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91, 7787-7791.